Mumbai (Maharashtra) [India], August 18: Impact Guru, India's leading medical crowdfunding platform, and Makers Hive, a trailblazing social impact startup, have announced their collaborative effort in launching the transformative campaign, "Kal Ki Asha". This joint initiative aims to empower
“We have revealed a protein pathway that appears to have a direct impact on diseases, which opens up a new area for potential drug development,” says the study’s senior author Aurelio Lorico, MD PhD, Professor of Pathology and interim Chief Research Officer at Touro University Nevada College
The gut microbiome has drawn the interest of academics and non-scientists alike over the last decade. A recent study has revealed that the bacteria and other microbes in our gut aid in immunity, metabolism, digestion, and the fight against "bad bacteria" that try to infiltrate our systems.
Although, after an argument, the health worker allowed the transgender to donate blood, this incident still raises various questions about why a transgender is stopped from donating blood.
Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dose, safety, and efficacy of a drug formulation designed to treat children infected with the human immunodeficiency virus (HIV).
Researchers at the University of Colorado Anschutz Medical Campus have contributed to the confirmation of the dose, safety, and efficacy of a medication formulation intended to treat children infected with the human immunodeficiency virus (HIV).
Dolutegravir is one of the most potent antiviral drugs now being used in clinical practise to treat HIV. Scientists from the Salk Institute and the National Institutes of Health have discovered the molecular routes through which the human immunodeficiency virus (HIV) develops resistance to i
To mark World Hepatitis Day (WHD), the WHO is calling for scaling up testing and treatment for viral hepatitis, warning that the disease could kill more people than malaria, tuberculosis, and HIV combined by 2040 if current infection trends continue.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Honey bees must balance effort, risk, and reward while making quick and accurate decisions about which blooms will supply food for their hive. According to a recent study published in the journal eLife, honey bees have evolved over millions of years to make swift decisions and limit danger.
The "viral infectivity factor (Vif)" of the HIV-1 virus can inhibit cellular defences. Cryo-electron microscopy has now been used by OIST researchers Prof. Matthias Wolf and Dr. Takahide Kouno as well as a global team of collaborators to discover the atomic structure of the "APOBEC3G-Vif com